United Urban Investment Corporation (8960.T)
JPY 135600.0
(0.07%)
JPY 135600.0
(0.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 50.4 Billion | 48.61 Billion | 47 Billion | 47.51 Billion | 51.93 Billion | 54.89 Billion |
| Cost of Revenue | 27.44 Billion | 22.71 Billion | 22.16 Billion | 21.64 Billion | 22.37 Billion | 24.57 Billion |
| Gross Profit | 22.96 Billion | 25.9 Billion | 24.84 Billion | 25.86 Billion | 29.55 Billion | 30.32 Billion |
| Operating Expenses | 712.09 Million | 4.72 Billion | 5.8 Billion | 4.59 Billion | 4.42 Billion | 4.33 Billion |
| Selling, General and Administrative Expenses | 175.83 Million | 4.19 Billion | 4.18 Billion | 4.11 Billion | 3.95 Billion | 3.87 Billion |
| Research and Development Expenses | - | 0.35 | 0.28 | 0.30 | 0.38 | 0.32 |
| Other Expenses | 518.18 Million | 3.06 Million | 1.61 Billion | 483.23 Million | 468.57 Million | 7.1 Million |
| Cost and Expenses | 28.15 Billion | 27.43 Billion | 27.96 Billion | 26.24 Billion | 26.79 Billion | 28.91 Billion |
| Operating Income | 22.31 Billion | 21.18 Billion | 19.04 Billion | 21.26 Billion | 25.13 Billion | 25.98 Billion |
| Interest Expense | 1.97 Billion | 1.89 Billion | 1.87 Billion | 1.99 Billion | 2.04 Billion | 2.15 Billion |
| Income Tax Expense | 1.21 Million | 1.21 Million | 1.21 Million | 1.21 Million | 1.21 Million | 1.21 Million |
| Earnings before Tax | 20.3 Billion | 19.29 Billion | 17.17 Billion | 19.28 Billion | 22.95 Billion | 23.76 Billion |
| Net Income | 20.29 Billion | 19.29 Billion | 17.17 Billion | 19.28 Billion | 22.95 Billion | 23.76 Billion |
| Earnings Per Share Basic | 6551.27 | 6191.08 | 5507.21 | 6183.87 | 7452.04 | 7777.92 |
| Earnings Per Share Diluted | 6551.27 | 6191.08 | 5507.21 | 6183.87 | 7452.04 | 7777.92 |
| Weighted Average Shares Outstanding | 3.09 Million | 3.11 Million | 3.11 Million | 3.11 Million | 3.08 Million | 3.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.09 Million | 3.11 Million | 3.11 Million | 3.11 Million | 3.08 Million | 3.05 Million |
| Gross Margin | 0.46 | 0.53 | 0.53 | 0.54 | 0.57 | 0.55 |
| EBIT Margin | 0.60 | 0.60 | 0.58 | 0.62 | 0.64 | 0.62 |
| Profit Margin | 0.40 | 0.40 | 0.37 | 0.41 | 0.44 | 0.43 |
| EBITDA | 30.44 Billion | 29.41 Billion | 28.41 Billion | 29.54 Billion | 33.31 Billion | 37.77 Billion |
| Earnings Before Tax Margin | 0.44 | 0.44 | 0.41 | 0.45 | 0.48 | 0.47 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 12.99 Billion | 12.99 Billion | 50.4 Billion | 25.35 Billion | 12.67 Billion | 25.05 Billion |
| Cost of Revenue | 6.7 Billion | 6.71 Billion | 27.44 Billion | 13.6 Billion | 6.81 Billion | 13.83 Billion |
| Gross Profit | 6.28 Billion | 6.27 Billion | 22.96 Billion | 11.75 Billion | 5.86 Billion | 11.21 Billion |
| Operating Expenses | 180.1 Million | 133.59 Million | 712.09 Million | 172.27 Million | 172.27 Million | 167.72 Million |
| Selling, General and Administrative Expenses | 43.94 Million | 39.43 Million | - | 35.1 Million | 35.1 Million | 43.46 Million |
| Research and Development Expenses | - | - | - | 109 Thousand | - | 111 Thousand |
| Other Expenses | 136.15 Million | - | -712.09 Million | 0.41 | - | 0.40 |
| Cost and Expenses | 6.88 Billion | 6.84 Billion | 28.15 Billion | 13.96 Billion | 6.98 Billion | 14.19 Billion |
| Operating Income | 6.1 Billion | 6.11 Billion | 22.25 Billion | 11.39 Billion | 5.7 Billion | 10.86 Billion |
| Interest Expense | - | - | 1.97 Billion | 1.02 Billion | - | 966.63 Million |
| Income Tax Expense | 302.5 Thousand | 302.5 Thousand | 1.21 Million | 605 Thousand | 302.5 Thousand | 605 Thousand |
| Earnings before Tax | 5.58 Billion | 5.58 Billion | 20.3 Billion | 10.37 Billion | 5.18 Billion | 9.93 Billion |
| Net Income | 5.58 Billion | 5.58 Billion | 20.29 Billion | 10.36 Billion | 5.18 Billion | 9.92 Billion |
| Earnings Per Share Basic | 1802.37 | 1802.37 | - | 3346.67 | 1699.72 | 3204.60 |
| Earnings Per Share Diluted | 1802.37 | 1802.37 | - | 3346.67 | 1699.72 | 3204.60 |
| Weighted Average Shares Outstanding | 3.09 Million | 3.09 Million | 3.09 Million | 3.09 Million | 3.05 Million | 3.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.09 Million | 3.09 Million | 3.09 Million | 3.09 Million | 3.05 Million | 3.09 Million |
| Gross Margin | 0.48 | 0.48 | 0.46 | 0.46 | 0.46 | 0.45 |
| EBIT Margin | 0.63 | 0.63 | - | 0.61 | 0.61 | 0.60 |
| Profit Margin | 0.43 | 0.43 | 0.40 | 0.41 | 0.41 | 0.40 |
| EBITDA | 8.14 Billion | 8.14 Billion | - | 15.46 Billion | 7.73 Billion | 14.92 Billion |
| Earnings Before Tax Margin | 0.47 | 0.47 | 0.44 | 0.45 | 0.45 | 0.43 |
ORCHPHARMA
SKHCF
CDGLY
008930
ZOREN
600703